What mechanism is central to achieving universal vaccine access in global health governance?

• A. Universal access mechanisms and production capacity.
• B. Private markets alone.
• C. Vaccine donations only from high-income countries.
• D. Regional exclusivity without sharing.

Answer: (A)

Universal vaccine access depends on coordinating universal access mechanisms with expanded production capacity. The idea is that even when a vaccine exists, getting it to every person requires deliberate systems that ensure affordability, fair allocation, financing, and predictable supply. Universal access mechanisms—such as pooled procurement, tiered pricing, financing arrangements, and licensing or technology-sharing to enable more manufacturers to produce vaccines—create the framework that makes vaccines reachable for all countries and populations. Production capacity is the other half: if enough vaccines can be manufactured, distributed, and delivered through robust supply chains, people can actually get vaccinated where they live.

Relying on private markets alone tends to favor those who can pay and can lead to shortages or unequal access. Donations from high-income countries, while helpful in some contexts, are irregular and do not reliably match global demand or reach every setting. Regional exclusivity without sharing fragments the supply chain and undermines the broader goal of universal access. When universal access mechanisms and broad production capacity work together, they address both the availability and the affordability and enable equitable vaccine coverage across the world.